InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,211.71
(
-1.07%
)
Post# of 251715
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 181175

Monday, 11/24/2014 8:45:04 AM

Monday, November 24, 2014 8:45:04 AM

Post# of 251715
Re: ENTA’s cash balance and liquidity

http://finance.yahoo.com/news/enanta-pharmaceuticals-reports-financial-results-123000964.html

ENTA’s cash balance at 9/30/14 was $131.8M, a slight decrease from the $137.6M at 6/30/14. Adding in the expected $150M in milestone payments from ABBV for FDA and EMA approval of the 3-DAA HCV regimen (#msg-100940717), absent a glitch ENTA’s cash should balloon to roughly $280M in the next couple of months, without even counting royalties on sales of ABBV’s 3-DAA regimen.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up